- Home
- NCNA vs DLXY Comparison
NCNA vs DLXY Comparison
Compare NCNA & DLXY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NCNA | DLXY |
|---|---|---|
| Founded | 1997 | 2007 |
| Country | United Kingdom | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.8M | 13.6M |
| IPO Year | 2017 | 2025 |
Fundamental Metrics
Financial Performance| Metric | NCNA | DLXY |
|---|---|---|
| Price | $3.25 | $0.91 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 83.3K | 71.8K |
| Earning Date | 11-13-2025 | 03-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 1077.13 |
| EPS | N/A | ★ 0.08 |
| Revenue | N/A | ★ $273,155,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $12.30 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.78 | $0.61 |
| 52 Week High | $268.00 | $7.16 |
Technical Indicators
Market Signals| Indicator | NCNA | DLXY |
|---|---|---|
| Relative Strength Index (RSI) | 41.26 | N/A |
| Support Level | $3.14 | N/A |
| Resistance Level | $3.35 | N/A |
| Average True Range (ATR) | 0.20 | 0.00 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 17.91 | 0.00 |
Price Performance
Historical ComparisonAbout NCNA NuCana plc
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.
About DLXY Delixy Holdings Limited Ordinary Shares
Delixy Holdings Ltd a holding company that operates through subsidiary. It is engaged in the trading of oil-related products, which can be categorized into crude oil, and oil-based products such as naphtha, motor gasoline, gas oil, fuel oil, asphalt, base oil, and other petrochemicals. The company has two reportable segments: the Sale of crude oil and the Sale of oil-based products. Key revenue is generated from the Sale of crude oil.